Decreased expression of the Augmenter of Liver Regeneration results in increased apoptosis and oxidative damage in human-derived glioma cells

Cell Death and Disease

Volumn 3, Issue 4, 2012, Pages

  Polimeno, L ^a,b   Pesetti, B ^b   De Santis, F ^a   Resta, L ^a   Rossi, R ^a   De Palma, A ^a   Girardi, B ^a   Amoruso, A ^a   Francavilla, A ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Apoptosis; Mitochondrial protection; Oxidative stress; ROS

Indexed keywords

AUGMENTER OF LIVER REGENERATION; CASPASE; CASPASE 3; CASPASE 9; CLUSTERIN; GROWTH FACTOR; GROWTH FACTOR ERV1; MESSENGER RNA; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; THIOL OXIDASE; UNCLASSIFIED DRUG; CYTOCHROME REDUCTASE; GFER PROTEIN, HUMAN; HYDROGEN PEROXIDE; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CELL DEGENERATION; ENZYME ACTIVATION; GLIOMA CELL; HUMAN; HUMAN CELL; MITOCHONDRION; MITOCHONDRION DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; RAT; RNA INTERFERENCE; TUMOR CELL LINE;

MAMMALIA; RATTUS;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CLUSTERIN; CYTOCHROME REDUCTASES; GENE EXPRESSION REGULATION; GLIOMA; HUMANS; HYDROGEN PEROXIDE; MITOCHONDRIA; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84862083135     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.25     Document Type: Article

References (40)

1. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002; 4: 278-299.
2. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003; 361: 323-331. (Pubitemid 36126198)
3. Mercer RW, Tyler MA, Ulasov IV, Lesniak MS. Targeted therapies for malignant glioma: progress and potential. BioDrugs 2009; 23: 25-35.
4. Lisowsky T, Lee JE, Polimeno L, Francavilla A, Hofhaus G. Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. Dig Liver Dis 2001; 33: 173-180. (Pubitemid 32294181)
5. Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T et al. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci USA 1994; 91: 8142-8146. (Pubitemid 24253902)
6. Polimeno L, Lisowsky T, Francavilla A. From yeast to man-from mitochondria to liver regeneration: a new essential gene family. Ital J Gastroenterol Hepatol 1999; 31: 494-500. (Pubitemid 29460324)
7. Polimeno L, Pesetti B, Giorgio F, Moretti B, Resta L, Rossi R et al. Expression and localization of augmenter of liver regeneration in human muscle tissue. Int J Exp Pathol 2009; 90: 423-430.
8. Yu HY, Xiang DR, Huang HJ, Li J, Sheng JF. Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2010; 9: 492-498.
9. Yang X, Xie L, Qiu Z, Wu Z, He F. Human augmenter of liver regeneration: Molecular cloning, biological activity and roles in liver regeneration. Sci China C Life Sci 1997; 40: 642-647. (Pubitemid 127489458)
10. Polimeno L, Pesetti B, Annoscia E, Giorgio F, Francavilla R, Lisowsky T et al. Alrp, a survival factor that controls the apoptotic process of regenerating liver after partial hepatectomy in rats. Free Radic Res 2011; 45: 534-549.
11. Thirunavukkarasu C, Wang LF, Harvey SA, Watkins SC, Chaillet JR, Prelich J et al. Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol 2008; 48: 578-588.
12. Polimeno L, Pesetti B, Lisowsky T, Iannone F, Resta L, Giorgio F et al. Protective effect of augmenter of liver regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Free Radic Res 2009; 43: 865-875.
13. Cao Y, Fu YL, Yu M, Yue PB, Ge CH, Xu WX et al. Human augmenter of liver regeneration is important for hepatoma cell viability and resistance to radiation-induced oxidative stress. Free Radic Biol Med 2009; 47: 1057-1066.
14. Todd LR, Damin MN, Gomathinayagam R, Horn SR, Means AR, Sankar U et al. Growth factor erv1-like modulates Drp1 to preserve mitochondrial dynamics and function in mouse embryonic stem cells. Mol Biol Cell 2010; 21: 1225-1236.
15. Liao XH, Zhang L, Liu Q, Sun H, Peng CM, Guo H. Augmenter of liver regeneration protects kidneys from ischaemia/reperfusion injury in rats. Nephrol Dial Transplant 2010; 25: 2921-2929.
16. Noh EM, Yi MS, Youn HJ, Lee BK, Lee YR, Han JH et al. Silibinin enhances ultraviolet B-induced apoptosis in mcf-7 human breast cancer cells. J Breast Cancer 2011; 14: 8-13.
17. Indrani IR, Tufo G, Pervaiz S, Brenner C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. BBA 2011; 1807: 735-745.
18. Hergartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-776.
19. Francavilla A, Hagiya M, Porter KA, Polimeno L, Ihara I, Starzl TE. Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology 1994; 20: 747-757. (Pubitemid 24271286)
20. Francavilla A, Ove P, Polimeno L, Coetzee M, Makowka L, Rose J et al. Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res. 1987; 47: 5600-5605. (Pubitemid 18046751)
21. Francavilla A, Starzl TE, Porter K, Foglieni CS, Michalopoulos GK, Carrieri G et al. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula. Hepatology 1991; 14: 665-670.
22. Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 1999; 29: 403-411. (Pubitemid 29088443)
23. Li Y, Wei K, Lu C, Li Y, Li M, Xing G et al. Identification of hepatopoietin dimerizzation, its interacting regions and alternative splicing of its transcript. Eur J Biochem 2002; 269: 3888-3893. (Pubitemid 34994883)
24. Wu CK, Dailey TA, Dailey HA, Wang BC, Rose JP. The cristal structure of Augmenter of liver regeneration: a mammalian FAD-dependent sulfhydryl oxidase. Protein Sci 2003; 12: 1109-1118. (Pubitemid 36505444)
25. Farrell SR, Thorpe C. Augmenter of liver regeneration: A flavin-dependent sulfhydryl oxidase with cytochrome c reductase activity. Biochemestry 2005; 44: 1532-1541. (Pubitemid 40204396)
26. Banci L, Bertini I, Calderone V, Cefaro C, Ciofi-Baffoni S, Gallo A et al. Molecular chaperone function of Mia40 triggers consecutive induced folding steps of the substrate in mitochondrial protein import. Proc Natl Acad Sci USA 2010; 107: 20190-20195.
27. Lange H, Lisowsky T, Gerber J, Mühlenhoff U, Kispal G, Lill R. An essential function of the mitochondrial sulfhydryl oxidase Erv1p/ALR in the maturation of cytosolic Fe/S proteins. EMBO Rep 2001; 2: 715-720. (Pubitemid 32798715)
28. Djeu JY, Wei S. Clusterin and chemoresistance. Adv Cancer Res 2009; 105: 77-92.
29. Gao CF, Zhou FG, Wang H, Huang YF, Ji Q, Chen J. Genetic recombinant expression and characterization of human augmenter of liver regeneration. Dig Dis Sci 2009; 54: 530-537.
30. Polimeno L, Capuano F, Marangi LC, Margiotta M, Lisowsky T, Ierardi E et al. The augmenter of liver regeneration induces mitochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mitochondria. Dig Liver Dis 2000; 32: 510-517.
31. Dewaele M, Maes H, Agostinis P. ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy. Autophagy 2010; 6: 838-854.
32. Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010; 38: 96-109.
33. Fruehauf JP, Meyskens Jr FL. Reactive Oxygen Species: A Breath of Life or Death? Clin Cancer Res 2007; 13: 789-794. (Pubitemid 46340350)
34. Konturek PC, Konturek SJ, Brzozowski T. Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol 2006; 57 (Suppl 3): 51-65. (Pubitemid 44617510)
35. Goldman A, Chen H, Khan MR, Roesly H, Hill KA, Shahidullah M et al. The Na/H exchanger controls deoxycholic Acid-induced apoptosis by a h-activated, Na-dependent ionic shift in esophageal cells. PLoS One 2011; 6: e23835.
36. Guan H, Zhang H, Cai J, Wu J, Yuan J, Li J et al. IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-kB. J Pathol 2011; 223: 436-445.
37. Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH, Lin YF et al. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Free Radic Biol Med 2011; 52: 377-391.
38. Senkevich TG, White CL, Koonin EV, Moss B. A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation. Proc Natl Acad Sci USA 2000; 97: 12068-12073.
39. Francavilla A, Vujanovic NL, Polimeno L, Azzarone A, Iacobellis A, Deleo A et al. The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology 1997; 25: 411-415. (Pubitemid 27069063)
40. Zhang L, Yu H, Sun Y, Lin X, Chen B, Tan C et al. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur J Pharmacol 2007; 564: 18-25. (Pubitemid 46946844)